Valuation ASKA Pharmaceutical Holdings Co.,Ltd.

Stocks

Delayed Japan Exchange 01:14:46 29/10/2026 GMT			5-day change	1st Jan Change
1,974.00 ^JPY	-0.40%		-2.61%	-3.04%

09-04	Metagen Therapeutics, Inc. announced that it has received ¥3.71 billion in funding from a group of investors	CI
08-04	ASKA Pharmaceutical Holdings Co.,Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	35,672	33,620	62,863	65,350	67,015	56,281	-	-
Change	-	-5.75%	86.98%	3.96%	2.55%	-16.02%	-	-
Enterprise Value (EV)	32,615	28,338	55,110	65,094	67,430	56,281	56,281	56,281
Change	-	-13.11%	94.47%	18.12%	3.59%	-16.53%	0%	0%
P/E	8.35x	7.92x	8.33x	12.8x	12.3x	12.1x	10.2x	8.75x
PBR	0.73x	0.62x	1.02x	1x	0.95x	0.77x	0.74x	0.7x
PEG	-	-10.51x	0.1x	-0.4x	1.98x	-0.9x	0.6x	0.5x
Capitalization / Revenue	0.63x	0.56x	1x	1.02x	0.94x	0.77x	0.75x	0.72x
EV / Revenue	0x	0x	0x	0x	0x	0.77x	0.75x	0.72x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	8.86x	7.56x	6.55x
EV / FCF	0x	0x	0x	-0x	0x	15.8x	11.5x	16.5x
FCF Yield	6.13%	6.17%	5.08%	-5.57%	5.37%	6.32%	8.71%	6.06%
Dividend per Share ²	15	16	40	55	60	65	70	74
Rate of return	1.19%	1.35%	1.8%	2.39%	2.54%	3.28%	3.53%	3.73%
EPS ²	151.2	150.1	266.5	180	191.1	164.4	194.5	226.4
Distribution rate	9.92%	10.7%	15%	30.6%	31.4%	39.5%	36%	32.7%
Net sales ¹	56,607	60,461	62,843	64,139	71,127	73,124	74,955	78,479
EBITDA	13,633	8,235	9,162	7,578	-	-	-	-
EBIT ¹	4,795	5,108	6,500	5,331	5,834	6,354	7,441	8,591
Net income ¹	4,290	4,238	7,545	5,101	5,424	4,669	5,524	6,429
Net Debt	-3,057	-5,282	-7,753	-256	415	-	-	-
Reference price ²	1,263.00	1,189.00	2,219.00	2,304.00	2,360.00	1,982.00	1,982.00	1,982.00
Nbr of stocks (in thousands)	28,243	28,276	28,329	28,364	28,396	28,396	-	-
Announcement Date	12/05/22	11/05/23	10/05/24	12/05/25	11/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.	12.15x	-	-	3.25%	359M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	27.84x	7.09x	18.77x	2.23%	402.79B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%